Core Viewpoint - Lassila & Tikanoja Plc has reported a transaction involving shares received by a manager as demerger consideration from Luotea Plc, indicating ongoing corporate restructuring and management changes within the company [1][2]. Group 1: Transaction Details - Eero Hautaniemi, the Chief Executive Officer, received 58,572 shares as part of the demerger consideration on December 31, 2025, with a unit price of 0 EUR [2]. - The transaction is categorized as an "OTHER" type, specifically related to the demerger consideration [2]. Group 2: Company Overview - Lassila & Tikanoja is a leading Nordic circular economy company focused on waste management, recycling, hazardous waste services, and water treatment [3]. - The company aims to promote sustainable material use and transform waste into valuable raw materials, employing approximately 2,300 people in Finland and Sweden [3].

Core Viewpoint - Lassila & Tikanoja Plc has reported a transaction involving shares received by a manager as demerger consideration from Luotea Plc, indicating ongoing corporate restructuring activities [1]. Group 1: Transaction Details - Tuija Kalpala, a member of the Board, received 1,486 shares as part of the demerger consideration on December 31, 2025, with a unit price of 0 EUR [2]. - The transaction is categorized as an "OTHER" type, specifically related to the demerger consideration [2]. Group 2: Company Overview - Lassila & Tikanoja is a leading Nordic circular economy company focused on waste management, recycling, and promoting sustainable material use [3]. - The company employs approximately 2,300 people in Finland and Sweden and is listed on Nasdaq Helsinki [3].

ECOLAB Third Quarter 2025 Supplemental 1 Cautionary statement Forward-Looking Information This communication contains forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding macroeconomic conditions and our financial and business performance and prospects, including sales, earnings, special (gains) and charges, raw material costs, margins, pricing, currency translation, ...

Core Viewpoint - Ecolab, Inc. is set to report its first-quarter 2025 results, with expectations of mixed performance across its segments, influenced by both growth opportunities and challenges in the current macroeconomic environment [1][9]. Global Industrial Segment - The Global Industrial segment, which includes Water, Food & Beverage, and Paper units, experienced sales growth in Q4 2024, particularly in the Water business, which is expected to positively impact overall industrial performance in the midterm [2][3]. - The Zacks Consensus Estimate for Q1 2025 revenues in the Global Industrial segment is $1.92 billion, reflecting a 4.1% increase from the previous year [4]. Global Institutional & Specialty Segment - The Global Institutional & Specialty segment showed strong growth in the last reported quarter, driven by new business and customer penetration, with expectations of continued revenue growth in Q1 2025 [5]. - The Zacks Consensus Estimate for Q1 2025 revenues in this segment is $1.37 billion, indicating a 7.9% increase from the prior year [6]. Other Contributing Factors - Ecolab's Life Sciences unit and Global Pest Elimination segment are also expected to contribute positively to revenues, with good new business wins and ongoing digital initiatives [7]. - However, the exit from non-strategic low-margin businesses in the Global Healthcare & Life Sciences segment may negatively impact performance [8]. Overall Revenue and EPS Estimates - The total revenue estimate for Q1 2025 is $3.70 billion, which represents a 1.4% decline from the previous year [9]. - The consensus estimate for EPS is $1.51, suggesting a 12.7% improvement from the prior-year period [10]. Share Price Performance - Over the past three months, Ecolab's shares have decreased by 3.6%, outperforming the Chemical - Specialty sector's decline of 6.6% and the S&P 500's decline of 10.9% [13]. - Comparatively, peers like Hawkins, Inc. and Givaudan SA have outperformed Ecolab, while Balchem Corporation has underperformed [17]. Valuation Metrics - Ecolab's forward 12-month price-to-earnings (P/E) ratio is 30.4X, which is higher than the industry average of 22.1X, indicating a premium valuation [18]. - The company trades at a premium compared to Hawkins but at a discount to peers like Balchem and Givaudan [19]. Long-Term Investment Outlook - Ecolab is making significant strides in its Global Water business and has engaged in partnerships to enhance water safety and efficiency, which are expected to bolster long-term growth [20]. - The Global Institutional & Specialty and Global Pest Elimination segments are aligning with long-term growth objectives, raising optimism about their profitability prospects [21]. Final Assessment - Ecolab demonstrates strong core business strength and growth potential, making it a suitable hold for existing investors [22]. - However, for new investors, the current valuation suggests limited growth potential compared to industry peers, advising caution before adding to positions [23].